These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22406117)

  • 1. Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Sun LQ; Qin B; Huang L; Qian K; Chen CH; Lee KH; Xie L
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2376-9. PubMed ID: 22406117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.
    Wei L; Wang HL; Huang L; Chen CH; Morris-Natschke SL; Lee KH; Xie L
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2788-2792. PubMed ID: 28465101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates.
    Sun LQ; Zhu L; Qian K; Qin B; Huang L; Chen CH; Lee KH; Xie L
    J Med Chem; 2012 Aug; 55(16):7219-29. PubMed ID: 22856541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Liu N; Qin B; Sun LQ; Yu F; Lu L; Jiang S; Lee KH; Xie L
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3719-23. PubMed ID: 25042339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus.
    Liu N; Wei L; Huang L; Yu F; Zheng W; Qin B; Zhu DQ; Morris-Natschke SL; Jiang S; Chen CH; Lee KH; Xie L
    J Med Chem; 2016 Apr; 59(8):3689-704. PubMed ID: 27070547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discovery and development of diarylpyrimidines (DAPYs) as next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
    Tian XT; Xie L
    Yao Xue Xue Bao; 2010 Feb; 45(2):177-83. PubMed ID: 21351427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Qin B; Jiang X; Lu H; Tian X; Barbault F; Huang L; Qian K; Chen CH; Huang R; Jiang S; Lee KH; Xie L
    J Med Chem; 2010 Jul; 53(13):4906-16. PubMed ID: 20527972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.
    Johnson BC; Pauly GT; Rai G; Patel D; Bauman JD; Baker HL; Das K; Schneider JP; Maloney DJ; Arnold E; Thomas CJ; Hughes SH
    Retrovirology; 2012 Dec; 9():99. PubMed ID: 23217210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,6-Di(arylamino)-3-fluoropyridine Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
    Sergeyev S; Yadav AK; Franck P; Michiels J; Lewi P; Heeres J; Vanham G; Ariën KK; Vande Velde CM; De Winter H; Maes BU
    J Med Chem; 2016 Mar; 59(5):1854-68. PubMed ID: 26785139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility.
    Frączek T; Kamiński R; Krakowiak A; Naessens E; Verhasselt B; Paneth P
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):9-16. PubMed ID: 29098886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
    Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR
    J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors.
    La Regina G; Coluccia A; Silvestri R
    Antivir Chem Chemother; 2010 Aug; 20(6):213-37. PubMed ID: 20710063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs.
    Ding L; Pannecouque C; De Clercq E; Zhuang C; Chen FE
    J Med Chem; 2021 Jul; 64(14):10297-10311. PubMed ID: 34197708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Dihydrothiopyrano[4,3-
    Wang Z; Zalloum WA; Wang W; Jiang X; De Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
    J Med Chem; 2021 Sep; 64(18):13658-13675. PubMed ID: 34432448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties.
    Kang D; Feng D; Sun Y; Fang Z; Wei F; De Clercq E; Pannecouque C; Liu X; Zhan P
    J Med Chem; 2020 May; 63(9):4837-4848. PubMed ID: 32293182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubility.
    Wang JS; Zhao KX; Zhang K; Pannecouque C; De Clercq E; Wang S; Chen FE
    Bioorg Chem; 2024 Jun; 147():107340. PubMed ID: 38593532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Novel Dihydrofuro[3,4-
    Kang D; Sun Y; Feng D; Gao S; Wang Z; Jing L; Zhang T; Jiang X; Lin H; De Clercq E; Pannecouque C; Zhan P; Liu X
    J Med Chem; 2022 Feb; 65(3):2458-2470. PubMed ID: 35061384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-human immunodeficiency virus activity of substituted ( o,o-difluorophenyl)-linked-pyrimidines as potent non-nucleoside reverse transcriptase inhibitors.
    Čechová L; Dejmek M; Baszczyňski O; Šaman D; Gao L; Hu E; Stepan G; Jansa P; Janeba Z; Šimon P
    Antivir Chem Chemother; 2019; 27():2040206619826265. PubMed ID: 30788976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.